Výsledky vyhledávání - Andrea Ruzza
- Zobrazuji výsledky 1 - 13 z 13
-
1
-
2
-
3
-
4
Long-term Low-Density Lipoprotein Cholesterol–Lowering Efficacy, Persistence, and Safety of Evolocumab in Treatment of Hypercholesterolemia Autor Michael J. Koren, Marc S. Sabatine, Robert P. Giugliano, Gisle Langslet, Stephen D. Wiviott, Helina Kassahun, Andrea Ruzza, Yuhui Ma, Ransi Somaratne, Frederick J. Raal
Vydáno 2017Artigo -
5
Evolocumab treatment in paediatric patients with homozygous familial hypercholesterolemia: Data from three pooled open-label studies Autor Frederick J. Raal, Andrea Ruzza, Jorge A. López, Anmol Bhatia, Jie Wu, H. Wang, D. Gaudet, Albert Wiegman, Robert A. Hegele, Raúl D. Santos
Vydáno 2023Artigo -
6
-
7
Evolocumab Treatment in Pediatric Patients With Homozygous Familial Hypercholesterolemia: Pooled Data From Three Open-Label Studies Autor Frederick J. Raal, Robert A. Hegele, Andrea Ruzza, J. Antonio G. López, Ajay Bhatia, Johnny Wu, Huei Wang, Daniel Gaudet, Albert Wiegman, Jian Wang, Raúl D. Santos
Vydáno 2024Artigo -
8
-
9
Evolocumab treatment reduces carotid intima-media thickness in paediatric patients with heterozygous familial hypercholesterolaemia Autor Albert Wiegman, Andrea Ruzza, G. Kees Hovingh, Raul D. Santos, François Mach, Claudia Stefanutti, Ilse K. Luirink, Ian Bridges, Bei Wang, Ajay Bhatia, Frederick J. Raal, John J.P. Kastelein, Daniel Gaudet
Vydáno 2024Artigo -
10
Evolocumab treatment reduces carotid intima-media thickness in paediatric patients with heterozygous familial hypercholesterolaemia Autor Albert Wiegman, Andrea Ruzza, G.K. Hovingh, Raúl D. Santos, François Mach, C. Stefanutti, Ilse K. Luirink, Ian Bridges, B Wang, A.K. Bhatia, Frederick J. Raal, John J.P. Kastelein, D. Gaudet
Vydáno 2022Artigo -
11
Cognitive function with evolocumab in pediatric heterozygous familial hypercholesterolemia Autor Daniel Gaudet, Andrea Ruzza, Ian Bridges, Paul Maruff, Adrian Schembri, Andrew Hamer, François Mach, Jean Bergeron, Isabelle Gaudet, Julie St‐Pierre, John J.P. Kastelein, G. Kees Hovingh, Albert Wiegman, Frederick J. Raal, Raúl D. Santos
Vydáno 2022Artigo -
12
Evolocumab in paediatric heterozygous familial hypercholesterolaemia: cognitive function during 80 weeks of open-label extension treatment Autor Raúl D. Santos, Andrea Ruzza, Bei Wang, Paul Maruff, Adrian Schembri, Ajay Bhatia, François Mach, Jean Bergeron, Isabelle Gaudet, Julie St‐Pierre, John J.P. Kastelein, G. Kees Hovingh, Albert Wiegman, Daniel Gaudet, Frederick J. Raal
Vydáno 2023Artigo -
13
Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia Autor Raúl D. Santos, Andrea Ruzza, G. Kees Hovingh, Albert Wiegman, François Mach, Christopher E. Kurtz, Andrew Hamer, Ian Bridges, Andrea Bartuli, Jean Bergeron, T Szamosi, Saikat Santra, Claudia Stefanutti, Olivier Descamps, Susanne Greber‐Platzer, Ilse K. Luirink, John J.P. Kastelein, Daniel Gaudet
Vydáno 2020Artigo
Vyhledávací nástroje:
Související témata
Medicine
Internal medicine
Apolipoprotein A1
Cholesterol
Evolocumab
Lipoprotein
LDL receptor
PCSK9
Familial hypercholesterolemia
Randomized controlled trial
Adverse effect
Alirocumab
Alternative medicine
Pathology
Placebo
Apolipoprotein B
Cardiology
Pediatrics
Randomization
Allele
Biology
Carotid arteries
Clinical endpoint
Clinical trial
Environmental health
Gastroenterology
Gene
Genetics
Heterozygote advantage
Intima-media thickness